Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Non-Current Assets (2020 - 2025)

Cellebrite DI's Non-Current Assets history spans 6 years, with the latest figure at $363.0 million for Q4 2025.

  • Quarterly Non-Current Assets rose 195.19% to $363.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $363.0 million through Dec 2025, up 195.19% year-over-year, with the annual reading at $363.0 million for FY2025, 195.19% up from the prior year.
  • Non-Current Assets came in at $363.0 million for Q4 2025, up from $165.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $363.0 million in Q4 2025 to a low of $43.8 million in Q3 2021.
  • The 5-year median for Non-Current Assets is $109.1 million (2022), against an average of $128.8 million.
  • Year-over-year, Non-Current Assets decreased 2.97% in 2023 and then surged 195.19% in 2025.
  • Cellebrite DI's Non-Current Assets stood at $66.6 million in 2021, then soared by 61.27% to $107.4 million in 2022, then grew by 3.21% to $110.8 million in 2023, then rose by 10.98% to $123.0 million in 2024, then soared by 195.19% to $363.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Non-Current Assets are $363.0 million (Q4 2025), $165.9 million (Q3 2025), and $181.3 million (Q2 2025).